Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Brian T. Weinert, Takeo Narita, Shankha Satpathy, et al.
Cell (2018) Vol. 174, Iss. 1, pp. 231-244.e12
Open Access | Times Cited: 420

Showing 1-25 of 420 citing articles:

Functions and mechanisms of non-histone protein acetylation
Takeo Narita, Brian T. Weinert, Chunaram Choudhary
Nature Reviews Molecular Cell Biology (2018) Vol. 20, Iss. 3, pp. 156-174
Closed Access | Times Cited: 933
Identification of bioactive metabolites using activity metabolomics
Markus M. Rinschen, Julijana Ivanišević, Martin Giera, et al.
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 6, pp. 353-367
Open Access | Times Cited: 827
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Michael A. Gillette, Shankha Satpathy, Song Cao, et al.
Cell (2020) Vol. 182, Iss. 1, pp. 200-225.e35
Open Access | Times Cited: 587
Modulation of cellular processes by histone and non-histone protein acetylation
Maria Shvedunova, Asifa Akhtar
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 5, pp. 329-349
Closed Access | Times Cited: 519
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Karsten Krug, Eric J. Jaehnig, Shankha Satpathy, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1436-1456.e31
Open Access | Times Cited: 402
Cell Adhesion by Integrins
Michaël Bachmann, Sampo Kukkurainen, Vesa P. Hytönen, et al.
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1655-1699
Open Access | Times Cited: 324
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
Ryan Raisner, Samir Kharbanda, Lingyan Jin, et al.
Cell Reports (2018) Vol. 24, Iss. 7, pp. 1722-1729
Open Access | Times Cited: 305
Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation
Marc A. Morgan, Ali Shilatifard
Nature Genetics (2020) Vol. 52, Iss. 12, pp. 1271-1281
Closed Access | Times Cited: 289
An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease
Raffaella Nativio, Yemin Lan, Greg Donahue, et al.
Nature Genetics (2020) Vol. 52, Iss. 10, pp. 1024-1035
Open Access | Times Cited: 278
The histone variant H2A.Z in gene regulation
Benedetto Daniele Giaimo, Francesca Ferrante, Andreas Herchenröther, et al.
Epigenetics & Chromatin (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 272
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination
Florian Wimmers, Michele Donato, Alex Kuo, et al.
Cell (2021) Vol. 184, Iss. 15, pp. 3915-3935.e21
Open Access | Times Cited: 214
Acetylation & Co: an expanding repertoire of histone acylations regulates chromatin and transcription
Claire E. Barnes, David M. English, Shaun M. Cowley
Essays in Biochemistry (2019) Vol. 63, Iss. 1, pp. 97-107
Open Access | Times Cited: 194
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Theresa E. Hickey, Luke A. Selth, Kee Ming Chia, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 310-320
Open Access | Times Cited: 188
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 159
The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes
Tasnim H. Beacon, Geneviève P. Delcuve, Camila López, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 158
Analysis of human acetylation stoichiometry defines mechanistic constraints on protein regulation
Bogi Karbech Hansen, Rajat Gupta, Linda Baldus, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 156
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
Takeo Narita, Shinsuke Ito, Yoshiki Higashijima, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2166-2182.e6
Open Access | Times Cited: 155
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
Yao‐Hui Huang, Kun Cai, Pengpeng Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 151
HBO1 is required for the maintenance of leukaemia stem cells
Laura MacPherson, Juliana Anokye, Miriam M. Yeung, et al.
Nature (2019) Vol. 577, Iss. 7789, pp. 266-270
Closed Access | Times Cited: 147
Cyclic immonium ion of lactyllysine reveals widespread lactylation in the human proteome
Ning Wan, Nian Wang, Siqin Yu, et al.
Nature Methods (2022) Vol. 19, Iss. 7, pp. 854-864
Closed Access | Times Cited: 144
Targeted degradation of the enhancer lysine acetyltransferases CBP and p300
Raghu Vannam, Jan Fehmi Sayılgan, Samuel Ojeda, et al.
Cell chemical biology (2021) Vol. 28, Iss. 4, pp. 503-514.e12
Open Access | Times Cited: 126
The transcription factor activity gradient (TAG) model: contemplating a contact-independent mechanism for enhancer–promoter communication
Jonathan P. Karr, John J. Ferrie, Robert Tjian, et al.
Genes & Development (2021) Vol. 36, Iss. 1-2, pp. 7-16
Open Access | Times Cited: 118
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Simon J. Hogg, Olga Motorna, Leonie A. Cluse, et al.
Molecular Cell (2021) Vol. 81, Iss. 10, pp. 2183-2200.e13
Open Access | Times Cited: 113
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma
Adam D. Durbin, Tingjian Wang, Virangika K. Wimalasena, et al.
Cancer Discovery (2021) Vol. 12, Iss. 3, pp. 730-751
Open Access | Times Cited: 112
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
Qingjuan Chen, Bin-Hui Yang, Xiaochen Liu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4935-4948
Open Access | Times Cited: 112
Page 1 - Next Page

Scroll to top